Projects per year
Personal profile
Chinese Name
符秀琼
Biography
Dr. Fu is currently a Research Assistant Professor at School of Chinese Medicine. She graduated with B.Sc. and M.Sc. degree in Southern Medical University in 2009 and 2012, respectively. She obtained his Ph.D. degree in pharmaceutical Sciences in Chinese Medicine from Hong Kong Baptist University in 2017. She then received postdoctoral training at the School of Chinese Medicine of Hong Kong Baptist University from 2017 to 2020.
Research Interests
Dr. Fu's research interests are anticancer properties of Chinese medicines and novel pathogenic factors of cancers.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Fingerprint
Dive into the research topics where Xiuqiong FU is active. Topic labels come from the works of this scholar.
- 1 Similar Scholars
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 2 Active
-
Use of Si-Jun-Zi-Tang as an adjuvant of temozolomide for treating melanoma
1/11/22 → 30/04/25
Project: Research project
-
Ranunculi Ternati Radix inhibits STAT3 signaling through upregulating miR-351 to exert anti-melanoma effects
1/09/21 → 31/08/23
Project: Research project
-
Inhibition of STAT3 signaling contributes to the anti-melanoma effects of chrysoeriol
Liu, Y. X., Chen, Y. J., Xu, B. W., Fu, X. Q., Ding, W. J., Li, S. M. A., Wang, X. Q., Wu, J. Y., Wu, Y., Dou, X., Liu, B. & Yu, Z. L., Jan 2023, In: Phytomedicine. 109, 11 p., 154572.Research output: Contribution to journal › Article › peer-review
-
Wenqingyin suppresses ferroptosis in the pathogenesis of sepsis-induced liver injury by activating the Nrf2-mediated signaling pathway
Xie, L., Zhou, C., Wu, Y., Fu, X., Zhang, G., Han, X., Xie, S., Chen, G., Xu, H., Deng, B., Liu, B., Zhou, Y. & Li, A., Jun 2023, In: Phytomedicine. 114, 13 p., 154748.Research output: Contribution to journal › Article › peer-review
-
Zhenwu decoction ameliorates cardiac hypertrophy through activating sGC (soluble guanylate cyclase) - cGMP (cyclic guanosine monophosphate) - PKG (protein kinase G) pathway
Chen, L., Zhou, X., Deng, Y., Yang, Y., Chen, X., Chen, Q., Liu, Y., Fu, X., Kwan, H. Y., You, Y., Jin, W. & Zhao, X., 10 Jan 2023, In: Journal of Ethnopharmacology. 300, 115705.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
具有抗大腸癌效果的藥物組合及其應用
YU, Z., FU, X. & LI, J., 4 Apr 2023, IPC No. A61-YZ-ISO3-CN01, 22 Sept 2021, Priority date 22 Sept 2021, Priority No. CN 202111106787.6Research output: Patent
-
基於網絡藥理學探討靈芝治療特應性皮炎的分子作用機制及有效成分
Translated title of the contribution :Study on the molecular mechanisms and bioactive compounds of Ganoderma lucidum in the treatment of atopic dermatitis based on network pharmacology Research output: Contribution to journal › Article › peer-review
Activities
- 1 Editor/reviewer for publications (incl. CDCF T61 Journal Editor)
-
Frontiers in Oncology (Journal)
Xiuqiong FU (Associate editor)
30 May 2022 → 30 May 2023Activity: Publication peer-review/editorial work › Editor/reviewer for publications (incl. CDCF T61 Journal Editor)